Literature DB >> 197786

Studies on the mechanism of flush induced by nicotinic acid.

R G Andersson, G Aberg, R Brattsand, E Ericsson, L Lundholm.   

Abstract

Flush is a common side effect of nicotinic acid therapy in patients. The effect is present as long as the level of nicotinic acid increases in the plasma. The mechanism of flush after nicotinic acid has been studied in the ears of guinea-pigs in vivo. The threshold dose of nicotinic acid (1-3 mg/kg) to raise the skin temperature of the ears and to increase the cyclic AMP level of this tissue was similar. Indomethacin and acetylsalicylic acid which inhibit the synthesis of prostaglandins markedly reduce the duration and intensity of the flush. In isolated slices from guinea-pig ears, nicotinic acid increased the level of cyclic AMP; this effect was inhibited by indomethacin. The stimulating action of prostaglandin E1 on the cyclic AMP level of the ear slices was not inhibited by indomethacin. Since administration to man of both cyclic AMP and prostaglandin E1 produces flush it is suggested that nicotinic acid may induce flush by the formation of some prostaglandin which then increases the formation of cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197786     DOI: 10.1111/j.1600-0773.1977.tb02116.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  15 in total

Review 1.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

2.  GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.

Authors:  Zoltán Benyó; Andreas Gille; Jukka Kero; Marion Csiky; Marie Catherine Suchánková; Rolf M Nüsing; Alexandra Moers; Klaus Pfeffer; Stefan Offermanns
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidil.

Authors:  G Haeusler; M Gerold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

4.  Central GPR109A Activation Mediates Glutamate-Dependent Pressor Response in Conscious Rats.

Authors:  Samar Rezq; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2015-11-30       Impact factor: 4.030

5.  Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.

Authors:  Julien Hanson; Andreas Gille; Sabrina Zwykiel; Martina Lukasova; Björn E Clausen; Kashan Ahmed; Sorin Tunaru; Angela Wirth; Stefan Offermanns
Journal:  J Clin Invest       Date:  2010-07-26       Impact factor: 14.808

6.  Primary Sjögren's syndrome treated with Efamol/Efavit. A double-blind cross-over investigation.

Authors:  R Manthorpe; S Hagen Petersen; J U Prause
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

Review 7.  Nicotinic acid: an old drug with a promising future.

Authors:  E T Bodor; S Offermanns
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

8.  beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice.

Authors:  Robert W Walters; Arun K Shukla; Jeffrey J Kovacs; Jonathan D Violin; Scott M DeWire; Christopher M Lam; J Ruthie Chen; Michael J Muehlbauer; Erin J Whalen; Robert J Lefkowitz
Journal:  J Clin Invest       Date:  2009-04-06       Impact factor: 14.808

9.  Flushing in rosacea: an experimental approach.

Authors:  A Parodi; M Guarrera; A Rebora
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

Review 10.  The mechanism and mitigation of niacin-induced flushing.

Authors:  V S Kamanna; S H Ganji; M L Kashyap
Journal:  Int J Clin Pract       Date:  2009-09       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.